These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17079920)

  • 21. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 22. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Education Program for Patient Self-Management of Warfarin.
    Jenner KM; Simmons BJ; Delate T; Clark NP; Kurz D; Witt DM
    Perm J; 2015; 19(4):33-8. PubMed ID: 26517434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a new method of warfarin management on patient satisfaction, time, and cost.
    Meyer S; Frei CR; Daniels KR; Forcade NA; Bussey M; Bussey-Smith KL; Bussey HI
    Pharmacotherapy; 2013 Nov; 33(11):1147-55. PubMed ID: 24038425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical inquiries. What is the interval for monitoring warfarin therapy once therapeutic levels have been achieved?
    Meurer LN; Jamieson B; Guthmann R
    J Fam Pract; 2005 Feb; 54(2):171-2. PubMed ID: 15689295
    [No Abstract]   [Full Text] [Related]  

  • 26. Training for patients in a randomised controlled trial of self management of warfarin treatment.
    Murray E; Fitzmaurice D; McCahon D; Fuller C; Sandhur H
    BMJ; 2004 Feb; 328(7437):437-8. PubMed ID: 14976099
    [No Abstract]   [Full Text] [Related]  

  • 27. Ask the doctors. There is a long list of drugs and substances that interact with Coumadin (warfarin). Does this mean they make Coumadin more effective, or less effective?
    Lee TH; Lee RT
    Harv Heart Lett; 2013 Sep; 24(1):2. PubMed ID: 24386674
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulation with warfarin. A review of monitoring issues.
    Vogel E
    Adv Nurse Pract; 2001 Jan; 9(1):75-8, 81, 94. PubMed ID: 12416044
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing the utility of an online registry for patients monitoring their own warfarin therapy.
    McCahon D; Baker JM; Murray ET; Fitzmaurice DA
    J Clin Pathol; 2016 Apr; 69(4):331-6. PubMed ID: 26519487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of direct observed therapy to confirm compliance in a warfarin clinic.
    Deen R
    J Patient Saf; 2011 Dec; 7(4):232-3. PubMed ID: 22064623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.
    Lim S; Houranieh J; Crawford R
    Am J Health Syst Pharm; 2014 Feb; 71(3):200-3. PubMed ID: 24429012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.
    Mohammad I; Korkis B; Garwood CL
    Pharmacotherapy; 2017 Oct; 37(10):1284-1297. PubMed ID: 28730690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of warfarin nonadherence on control of the International Normalized Ratio.
    Waterman AD; Milligan PE; Bayer L; Banet GA; Gatchel SK; Gage BF
    Am J Health Syst Pharm; 2004 Jun; 61(12):1258-64. PubMed ID: 15259756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indeterminable international normalized ratio with concurrent use of warfarin and gatifloxacin.
    Chock AW; Stading JA
    Am J Health Syst Pharm; 2006 Aug; 63(16):1539-42. PubMed ID: 16896082
    [No Abstract]   [Full Text] [Related]  

  • 38. Monitoring Coumadin-the original oral anticoagulant.
    McGlasson DL
    Clin Lab Sci; 2013; 26(1):43-7. PubMed ID: 23479836
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential interaction between warfarin and ocular chloramphenicol.
    Leone R; Ghiotto E; Conforti A; Velo G
    Ann Pharmacother; 1999 Jan; 33(1):114. PubMed ID: 9972397
    [No Abstract]   [Full Text] [Related]  

  • 40. Curbside Coumadin Clinics Offer Testing During COVID-19 Crisis.
    Ostroff J; Roggie S; Opitz B
    J Pharm Pract; 2020 Dec; 33(6):734-735. PubMed ID: 32757848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.